ATE112686T1 - Verwendungsmethoden von humanem gammainterferon 4-134. - Google Patents

Verwendungsmethoden von humanem gammainterferon 4-134.

Info

Publication number
ATE112686T1
ATE112686T1 AT91917729T AT91917729T ATE112686T1 AT E112686 T1 ATE112686 T1 AT E112686T1 AT 91917729 T AT91917729 T AT 91917729T AT 91917729 T AT91917729 T AT 91917729T AT E112686 T1 ATE112686 T1 AT E112686T1
Authority
AT
Austria
Prior art keywords
methods
ifn gamma
gamma interferon
human gamma
gamma
Prior art date
Application number
AT91917729T
Other languages
English (en)
Inventor
Satwant K Narula
Daniel J Lundell
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE112686T1 publication Critical patent/ATE112686T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91917729T 1990-08-31 1991-08-29 Verwendungsmethoden von humanem gammainterferon 4-134. ATE112686T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57624590A 1990-08-31 1990-08-31

Publications (1)

Publication Number Publication Date
ATE112686T1 true ATE112686T1 (de) 1994-10-15

Family

ID=24303564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917729T ATE112686T1 (de) 1990-08-31 1991-08-29 Verwendungsmethoden von humanem gammainterferon 4-134.

Country Status (7)

Country Link
EP (1) EP0546099B1 (de)
JP (1) JPH06501001A (de)
AT (1) ATE112686T1 (de)
AU (1) AU8640091A (de)
CA (1) CA2090478A1 (de)
DE (1) DE69104619T2 (de)
WO (1) WO1992004377A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0203409A3 (en) 1999-11-12 2005-06-28 Maxygen Holdings Ltd Redwood C Interferon gamma conjugates
YU32402A (sh) 1999-11-12 2005-03-15 Maxygen Holdings Ltd. Konjugati gama interferona
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
CA2491178A1 (en) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
DE3782960T2 (de) * 1986-03-17 1993-04-29 Boehringer Ingelheim Int Impfstoffe.
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
DE3730331A1 (de) * 1987-09-10 1989-03-30 Basf Ag Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6

Also Published As

Publication number Publication date
WO1992004377A1 (en) 1992-03-19
EP0546099B1 (de) 1994-10-12
DE69104619T2 (de) 1995-04-13
JPH06501001A (ja) 1994-01-27
AU8640091A (en) 1992-03-30
CA2090478A1 (en) 1992-03-01
DE69104619D1 (de) 1994-11-17
EP0546099A1 (de) 1993-06-16

Similar Documents

Publication Publication Date Title
ATE82508T1 (de) Synergistische mischungen von interferonen und tumor-nekrose-faktor.
DK0751959T3 (da) Modificerede polypeptider med forøget biologisk aktivitet
DE69230140D1 (de) Antivirale nucleosidkombination
MX9206741A (es) Composiciones combinadas de limpieza y humedecimiento personal.
ATE219366T1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
YU26691A (sh) BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
ATE81978T1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DE69124258D1 (de) Tertiäre azeotrope zusammensetzungen von 43-10mee (cf 3?chfchfcf 2?cf 3?) und trans 1,2-dichloroethylen mit methanol oder ethanol
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
DE3650733D1 (de) Pharmazeutische Zubereitungen und medizinische Verwendungen von Dioxopiperidinderivaten, insbesondere als Verstärker der Immunantwort sowie als antivirale und antibakterielle Wirkstoffe
NZ329970A (en) Use of IFN-beta mutein derivatives for treating viral infections
DE68915128D1 (de) Derivate von 2'-Halomethyliden, 2'-Ethenyliden und 2'-Ethynylcytidin, Uridin und Guanosin.
FI860018A0 (fi) Laekemedelspreparat med reducerad toxisitet.
ATE112686T1 (de) Verwendungsmethoden von humanem gammainterferon 4-134.
BR9710206A (pt) Uso de um agente de interleucina-8 e formulação farmacéutica antiviral
MX9201866A (es) Derivados de 2-amino pirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica.
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
FI911269A7 (fi) Menetelmä ja koostumus aktiivisten aineiden lisääntyneen pitoisuuden aikaansaamiseksi iholla iontoforeesin avulla
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
DE3585643D1 (de) Antiviren-verbindungen, behandlung und formulierungen.
DE69208681D1 (de) Verwendungen von 1,1,1,3,3,3-hexafluoropropan
ATE100717T1 (de) Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons.
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE3869789D1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties